Olivier Chambenoit Selected Research

Cytokines

1/2019

An Investigation of Comorbid Disease and Health Service Utilization Among Patients With Moderate to Severe Psoriasis in Newfoundland and Labrador.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Chambenoit Research Topics

Disease

6	Psoriatic Arthritis 01/2022 - 11/2018
5	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2021 - 11/2018
1	Urticaria (Hives) 07/2020
1	Chronic Urticaria 07/2020
1	Ankylosing Spondylitis 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Cadaver (Cadavers) 12/2002
1	Dyslipidemias (Dyslipidemia) 12/2002

Drug/Important Bio-Agent (IBA)

5	secukinumabIBA 01/2022 - 01/2019
2	Adalimumab (Humira)FDA Link 01/2019 - 11/2018
2	Etanercept (Enbrel)FDA Link 01/2019 - 11/2018
1	Tumor Necrosis Factor InhibitorsIBA 09/2021
1	Omalizumab (Xolair)FDA Link 07/2020
1	golimumab FDA Link 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Certolizumab Pegol FDA Link 01/2019
1	CytokinesIBA 01/2019
1	Infliximab (Remicade)FDA Link 11/2018
1	Ustekinumab (CNTO 1275)FDA Link 11/2018
1	PhosphatidylserinesIBA 12/2002
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2002
1	ApolipoproteinsIBA 12/2002

Therapy/Procedure

3	Biological Therapy 01/2019 - 11/2018
2	Therapeutics 01/2019 - 01/2019
1	Aftercare (After-Treatment) 07/2020
1	Phototherapy (Light Therapy) 01/2019